Sung‐Yup Cho

1.7k total citations
56 papers, 878 citations indexed

About

Sung‐Yup Cho is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sung‐Yup Cho has authored 56 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Sung‐Yup Cho's work include Blood properties and coagulation (17 papers), Erythrocyte Function and Pathophysiology (8 papers) and RNA modifications and cancer (7 papers). Sung‐Yup Cho is often cited by papers focused on Blood properties and coagulation (17 papers), Erythrocyte Function and Pathophysiology (8 papers) and RNA modifications and cancer (7 papers). Sung‐Yup Cho collaborates with scholars based in South Korea, United States and Ethiopia. Sung‐Yup Cho's co-authors include In Gyu Kim, Dong‐Myung Shin, Eui Man Jeong, Ju‐Hong Jeon, Chai-Wan Kim, Jin-Haeng Lee, Charles Lee, Kyungho Choi, Jinjoo Kang and Ahra Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Sung‐Yup Cho

52 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sung‐Yup Cho South Korea 17 354 263 171 130 89 56 878
Soo‐Youl Kim South Korea 19 541 1.5× 388 1.5× 131 0.8× 181 1.4× 154 1.7× 31 1.1k
Weihua Tian Denmark 17 661 1.9× 124 0.5× 240 1.4× 106 0.8× 54 0.6× 34 968
Lin Ye China 19 737 2.1× 155 0.6× 184 1.1× 331 2.5× 47 0.5× 45 1.1k
Shunzi Jin China 19 499 1.4× 194 0.7× 182 1.1× 279 2.1× 80 0.9× 54 1.1k
Xiaocong Pang China 16 506 1.4× 153 0.6× 168 1.0× 230 1.8× 43 0.5× 45 873
Yee Chan‐Li United States 17 383 1.1× 192 0.7× 153 0.9× 205 1.6× 127 1.4× 34 1.1k
Zeng Fan China 17 609 1.7× 87 0.3× 278 1.6× 191 1.5× 76 0.9× 62 1.2k
Daniela Annibali Belgium 18 601 1.7× 104 0.4× 295 1.7× 257 2.0× 55 0.6× 29 1.0k
Ya‐Ju Hsieh Taiwan 14 509 1.4× 184 0.7× 104 0.6× 237 1.8× 52 0.6× 29 876

Countries citing papers authored by Sung‐Yup Cho

Since Specialization
Citations

This map shows the geographic impact of Sung‐Yup Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung‐Yup Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung‐Yup Cho more than expected).

Fields of papers citing papers by Sung‐Yup Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung‐Yup Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung‐Yup Cho. The network helps show where Sung‐Yup Cho may publish in the future.

Co-authorship network of co-authors of Sung‐Yup Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Sung‐Yup Cho. A scholar is included among the top collaborators of Sung‐Yup Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung‐Yup Cho. Sung‐Yup Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryu, Yong‐Woon, et al.. (2025). Proteogenomic Analysis on RNA m6A Modification-Associated Genes Identifies a Distinct Subgroup with High IGF2BPs Expression Across Cancer Types. International Journal of Medical Sciences. 22(15). 3815–3827.
3.
Choi, Soo In, et al.. (2024). The Effect of Clostridium butyricum on Gut Microbial Changes and Functional Profiles of Metabolism in High-fat Diet–fed Rats Depending on Age and Sex. Journal of Neurogastroenterology and Motility. 30(2). 236–250. 3 indexed citations
4.
Jung, Hae Rim, Jeonghwan Lee, Nayeon Shin, et al.. (2024). Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. Experimental & Molecular Medicine. 56(2). 355–369. 24 indexed citations
5.
Suh, Jungyo, Moses Lee, Minyong Kang, et al.. (2024). Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma. Experimental & Molecular Medicine. 56(8). 1807–1815. 4 indexed citations
6.
Kim, Jong Seung, Cheulhee Jung, Nam‐Jung Kim, et al.. (2024). Discovery of thiophen-2-ylmethylene bis-dimedone derivatives as novel WRN inhibitors for treating cancers with microsatellite instability. Bioorganic & Medicinal Chemistry. 100. 117588–117588. 6 indexed citations
7.
Shin, Ji‐Woong, et al.. (2023). Transglutaminase 2 Prevents Premature Senescence and Promotes Osteoblastic Differentiation of Mesenchymal Stem Cells through NRF2 Activation. Stem Cells International. 2023. 1–16. 5 indexed citations
8.
Jung, Hae Rim, Yumi Oh, Soojin Lee, et al.. (2022). Gut bacteria-derived 3-phenylpropionylglycine mitigates adipocyte differentiation of 3T3-L1 cells by inhibiting adiponectin-PPAR pathway. Genes & Genomics. 45(1). 71–81. 3 indexed citations
9.
Jun, Eunsung, Jee Young Kwon, Jaesang Kim, et al.. (2022). Direct cell-to-cell transfer in stressed tumor microenvironment aggravates tumorigenic or metastatic potential in pancreatic cancer. npj Genomic Medicine. 7(1). 63–63. 11 indexed citations
10.
Kim, Hye Young, Min Jueng Kang, Yumi Oh, et al.. (2021). Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2. eLife. 10. 8 indexed citations
11.
Cho, Sung‐Yup, Yukyung Jun, Deukchae Na, et al.. (2020). Genome‐scale CRISPR screening identifies cell cycle and protein ubiquitination processes as druggable targets for erlotinib‐resistant lung cancer. Molecular Oncology. 15(2). 487–502. 20 indexed citations
12.
Cho, Sung‐Yup, Seungun Lee, Jeonghun Yeom, et al.. (2020). Transglutaminase 2 mediates hypoxia-induced selective mRNA translation via polyamination of 4EBPs. Life Science Alliance. 3(3). e201900565–e201900565. 5 indexed citations
13.
Cho, Sung‐Yup. (2020). Patient-derived xenografts as compatible models for precision oncology. SHILAP Revista de lepidopterología. 36(1). 14–14. 40 indexed citations
14.
Cho, Sung‐Yup, Jeesoo Chae, Deukchae Na, et al.. (2019). Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers. Clinical Cancer Research. 25(9). 2821–2834. 13 indexed citations
15.
Jeong, Eui Man, Jihye Yoon, Jisun Lim, et al.. (2018). Real-Time Monitoring of Glutathione in Living Cells Reveals that High Glutathione Levels Are Required to Maintain Stem Cell Function. Stem Cell Reports. 10(2). 600–614. 99 indexed citations
16.
Cho, Sung‐Yup, Jee Yun Han, Deukchae Na, et al.. (2017). A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF -mutated and BCL2L1 -amplified Colorectal Cancers. Molecular Cancer Therapeutics. 16(10). 2178–2190. 12 indexed citations
17.
Min, Sangil, Eui Man Jeong, Sung‐Yup Cho, et al.. (2014). Intimal Hyperplasia in Loop-Injured Carotid Arteries Is Attenuated in Transglutaminase 2-Null Mice. Journal of Korean Medical Science. 29(3). 363–363. 3 indexed citations
18.
Cho, Sung‐Yup, Ju‐Hong Jeon, Chai-Wan Kim, et al.. (2010). Monoclonal Antibodies to Human Transglutaminase 4. Hybridoma. 29(3). 263–267. 5 indexed citations
19.
Jeon, Ju‐Hong, Hye-Jin Lee, Chai-Wan Kim, et al.. (2004). Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine. Experimental & Molecular Medicine. 36(6). 576–581. 35 indexed citations
20.
Jeon, Ju‐Hong, Sung‐Yup Cho, Chai-Wan Kim, et al.. (2002). Improved immunodetection of human papillomavirus E7. Experimental & Molecular Medicine. 34(6). 496–499. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026